Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Lynparza on cusp of EU approval for advanced ovarian cancer
Pharmaforum
Mon, 04/29/19 - 10:28 am
Tags:
AstraZeneca, Lynparza, Europe, CHMP, ovarian cancer
Soriot sees progress in U.S.-China IP debate
BioCentury
Sat, 04/27/19 - 10:36 am
Tags:
China, AstraZeneca, Pascal Soriot, intellectual property
AstraZeneca dumps Amgen-partnered drug after midphase fail
Fierce Biotech
Fri, 04/26/19 - 11:46 am
Tags:
AstraZeneca, Amgen, prezalumab, Sjöogren’s syndrome
Newer drugs fuel AstraZeneca quarterly sales beat
Yahoo/Reuters
Fri, 04/26/19 - 10:34 am
Tags:
AstraZeneca, earnings
Pfizer, AstraZeneca and J&J Take Issue With FDA’s List of Companies Withholding Drug Samples
RAPS.org
Fri, 04/12/19 - 11:46 pm
Tags:
generics, Pfizer, AstraZeneca, JNJ
GSK, AstraZeneca explore continuous manufacturing in partnership with CPI
Biopharma Dive
Thu, 04/11/19 - 07:21 pm
Tags:
GSK, AstraZeneca, continuous manufacturing, drug manufacturing
AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer
Pharmaforum
Wed, 04/10/19 - 09:46 am
Tags:
AstraZeneca, Merck, Lynparza, BRCA-mutant breast cancer, Europe, breast cancer
PhaseBio touts 'breakthrough' badge for bloodthinner reversal agent licensed from AstraZeneca, shares leap
Endpoints
Tue, 04/9/19 - 08:22 am
Tags:
PhaseBio, Brilinta, PB2452, bloodthinner reversals, breakthrough status, AstraZeneca
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
Tags:
JNJ, Roche, Pfizer, Novartis, Merck, GSK, Sanofi, AbbVie, Bayer, Eli Lilly, Amgen, Bristol-Myers Squibb, Gilead Sciences, Teva Pharmaceutical, AstraZeneca
AstraZeneca’s asthma drug Fasenra looks promising for a set of rare chronic immune diseases
Endpoints
Thu, 04/4/19 - 10:30 am
Tags:
AstraZeneca, Fasenra, asthma, HES, FDA
Early pancreatic cancer data give Clovis a new path in PARP market
Biopharma Dive
Tue, 04/2/19 - 04:22 pm
Tags:
pancreatic cancer, Clovis Oncology, AstraZeneca, PARP inhibitors, AACR, Rubraca, Lynparza
AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion
Barron's
Tue, 04/2/19 - 12:01 pm
Tags:
AstraZeneca
Circassia gets dual boost for US COPD drugs
Pharmaforum
Mon, 04/1/19 - 10:39 am
Tags:
Circassia, FDA, COPD, Tudorza, Duaklir, AstraZeneca
Chi-Med, AstraZeneca's savolitinib helps some Tagrisso-resistant EGFR lung cancer patients
Fierce Pharma
Sun, 03/31/19 - 03:44 pm
Tags:
Chi-Med, savolitinib, AstraZeneca, Tagrisso, EGFR lung cancer
AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal
Yahoo/Reuters
Fri, 03/29/19 - 10:06 am
Tags:
AstraZeneca, Daiichi Sankyo, breast cancer, trastuzumab deruxtecan
Aveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition
BioSpace
Thu, 03/28/19 - 12:06 pm
Tags:
AstraZeneca, Aveo Oncology, M&A
AstraZeneca's Imfinzi gets a lift in lung cancer from England's cost watchdogs
Fierce Pharma
Thu, 03/28/19 - 11:50 am
Tags:
AstraZeneca, Imfinzi, lung cancer, NICE, UK
AstraZeneca to help build new life science research cluster in China
Fierce Biotech
Thu, 03/28/19 - 11:38 am
Tags:
AstraZeneca, China, R&D
AZ’s diabetes drug Forxiga approved in EU for type 1 disease
Pharmaforum
Mon, 03/25/19 - 10:17 am
Tags:
AstraZeneca, type 1 diabetes diabetes, Europe, Forxiga, Farixga
Microbiome Report for Week Ending 3/16/19
CP Wire
Fri, 03/22/19 - 10:01 am
Tags:
microbiome, Seres Therapeutics, AstraZeneca, stroke

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.